Product Information
NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1916 per GM under NDC 62332060660. Its NADAC has been published 273 times since Jul 14, 2021.
FDA first approved this application on Mar 31, 2021. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332060660
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214090FDA Approved
3/31/2021
TE Code
AT
On Market Since
4/2/2021
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 273 times since Jul 14, 2021, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1916 per GM |
|---|---|
| All-time high | $0.4699 (Feb 16, 2022) |
| All-time low | $0.1818 (Nov 20, 2024) |
| 52-week high | $0.2157 |
| 52-week low | $0.1893 |
| Median price | $0.2285 |
| Average price | $0.2526 |
| Largest weekly change | +59.9% (Nov 22, 2023) |
| Weeks tracked | 273 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin and Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Alembic Pharmaceuticals Inc., is $0.1916 per GM (NDC 62332060660), effective Sep 30, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 19.0%. It has been tracked across 273 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?
Since Jul 14, 2021, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.1818 (Nov 20, 2024) to a high of $0.4699 (Feb 16, 2022), with a median of $0.2285 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NYSTATIN-TRIAMCINOLONE CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?
NYSTATIN-TRIAMCINOLONE CREAM (NDC 62332060660) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.